New lab technology available for demonstrations on mobile semi-tractor trailers to visit 100+ cities nationwide
INDIANAPOLIS, Feb. 8 -- Roche Diagnostics unveils two customized, fully-equipped "lab on wheels" semi-tractor trailers. The two mobile demonstration centers, called the Roche Explorers, began their cross-country trek this week with the first stop taking place in Atlanta, GA. This set in motion a 100+ city nationwide tour for 2007.
The state-of-the-art Roche Explorers will showcase solutions for laboratory testing. Our goal is to educate current and potential customers about the products Roche Diagnostics offer. Roche Explorers give lab personnel the opportunity to see and understand how new technology can help improve efficiency in their hospital labs and in turn can help their physicians deliver improved patient care.
"By taking the Roche lab solutions on the road, we hope to reinforce our commitment to our customers by making their lives easier when we bring the Roche experience to them," Andy Thomson, Senior Vice President, Roche Centralized Diagnostics said. "With our new mobile demonstration centers, we now have the ability to reach a wider base of lab personnel that might not be familiar with our products and technologies."
Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is a world leader in diagnostics, the leading supplier of drugs for cancer and transplantation and a market leader in virology. In 2006, sales by the Pharmaceuticals Division totalled 33.3 billion Swiss francs, and the Diagnostics Division posted sales of 8.7 billion Swiss francs. Roche employs roughly 75,000 people in 150 countries and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai. For further information, please visit our website www.roche-diagnostics.us.
Source: Roche Diagnostics
For further information please contact:
Web site: www.roche.com/